Building the drug-GO function network to screen significant candidate drugs for myasthenia gravis.
Li S, Cao Y, Li L, Zhang H, Lu X, Bo C, Kong X, Liu Z, Chen L, Liu P, Jiao Y, Wang J, Ning S, Wang L.
Li S, et al. Among authors: chen l.
PLoS One. 2019 Apr 4;14(4):e0214857. doi: 10.1371/journal.pone.0214857. eCollection 2019.
PLoS One. 2019.
PMID: 30947317
Free PMC article.